ZLAB Stock Analysis: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$19.31
0.23 (1.21%)
▲
5d:
+4.89%
30d:
+11.36%
90d:
-5.8%
BUY
MODERATE Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
29d
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ZLAB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ZLAB shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $19.31, which is considered extended relative to its 30-day fair value range of $17.08 to $18.74.
Technical Outlook: Technically, ZLAB is showing sideways momentum. The price is approaching resistance at $19.61. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.30 (+74.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZLAB is showing sideways momentum. The price is approaching resistance at $19.61. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ZLAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.30 (+74.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.08 -
$18.74
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 74.5% below Wall St target ($33.30)
Trading Range Analysis
30-Day Trading Range
$17.08 -
$18.74
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.23
Resistance Level
$19.61
Current Trend
Sideways
Technical data as of
Jul 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.93
Wall Street Target
$33.30
(+74.5%)
Revenue Growth (YoY)
-6.5%
Profit Margin
-39.3%
Share & Embed Analysis
Last updated: July 07, 2026 3:36 PM ET
Data refreshes hourly during market hours. Next update: 4:35 PM
Data refreshes hourly during market hours. Next update: 4:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado
SELL
2739 shares
2026-04-06
Yajing Chen
SELL
853 shares
2026-04-06
Ying Du
SELL
2653 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 65 BUY |
